OneAscent Financial Services LLC cut its stake in McKesson Co. (NYSE:MCK – Free Report) by 28.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 920 shares of the company’s stock after selling 367 shares during the quarter. OneAscent Financial Services LLC’s holdings in McKesson were worth $495,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Norges Bank purchased a new stake in shares of McKesson during the fourth quarter valued at approximately $1,024,140,000. International Assets Investment Management LLC increased its position in shares of McKesson by 1,044.5% during the fourth quarter. International Assets Investment Management LLC now owns 821,262 shares of the company’s stock valued at $380,228,000 after acquiring an additional 749,504 shares during the last quarter. TD Asset Management Inc increased its position in shares of McKesson by 202.8% during the fourth quarter. TD Asset Management Inc now owns 602,138 shares of the company’s stock valued at $278,778,000 after acquiring an additional 403,312 shares during the last quarter. Morgan Stanley increased its position in shares of McKesson by 14.0% during the third quarter. Morgan Stanley now owns 2,398,380 shares of the company’s stock valued at $1,042,937,000 after acquiring an additional 294,832 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of McKesson by 5,683.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 225,016 shares of the company’s stock valued at $104,178,000 after acquiring an additional 221,125 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $574.41, for a total value of $2,155,760.73. Following the transaction, the chief executive officer now owns 89,845 shares in the company, valued at $51,607,866.45. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, Director Susan R. Salka sold 606 shares of McKesson stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $558.04, for a total value of $338,172.24. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $574.41, for a total value of $2,155,760.73. Following the completion of the transaction, the chief executive officer now owns 89,845 shares in the company, valued at approximately $51,607,866.45. The disclosure for this sale can be found here. Insiders sold a total of 25,814 shares of company stock valued at $14,511,649 over the last 90 days. Insiders own 0.21% of the company’s stock.
Analysts Set New Price Targets
View Our Latest Stock Analysis on McKesson
McKesson Price Performance
MCK stock traded down $9.16 during mid-day trading on Friday, hitting $584.04. 1,240,773 shares of the stock were exchanged, compared to its average volume of 626,370. The business has a fifty day moving average price of $565.88 and a 200 day moving average price of $524.60. McKesson Co. has a 12 month low of $395.30 and a 12 month high of $612.17. The stock has a market capitalization of $75.89 billion, a price-to-earnings ratio of 26.10, a PEG ratio of 1.39 and a beta of 0.47.
McKesson (NYSE:MCK – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.34 by ($0.16). McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The firm had revenue of $76.36 billion for the quarter, compared to the consensus estimate of $79.32 billion. During the same period last year, the firm earned $7.19 EPS. The company’s revenue for the quarter was up 10.8% on a year-over-year basis. As a group, equities analysts forecast that McKesson Co. will post 31.54 EPS for the current fiscal year.
McKesson Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Monday, June 3rd will be paid a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend is Monday, June 3rd. McKesson’s dividend payout ratio (DPR) is currently 11.08%.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- Canadian Penny Stocks: Can They Make You Rich?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Pros And Cons Of Monthly Dividend Stocks
- MarketBeat Week in Review – 6/24 – 6/28
- Financial Services Stocks Investing
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.